Cargando…
Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study
BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definit...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793465/ https://www.ncbi.nlm.nih.gov/pubmed/33447639 http://dx.doi.org/10.1093/ofid/ofaa578 |
_version_ | 1783633997440483328 |
---|---|
author | Karaba, Sara M Jones, George Helsel, Taylor Smith, L Leigh Avery, Robin Dzintars, Kathryn Salinas, Alejandra B Keller, Sara C Townsend, Jennifer L Klein, Eili Amoah, Joe Garibaldi, Brian T Cosgrove, Sara E Fabre, Valeria |
author_facet | Karaba, Sara M Jones, George Helsel, Taylor Smith, L Leigh Avery, Robin Dzintars, Kathryn Salinas, Alejandra B Keller, Sara C Townsend, Jennifer L Klein, Eili Amoah, Joe Garibaldi, Brian T Cosgrove, Sara E Fabre, Valeria |
author_sort | Karaba, Sara M |
collection | PubMed |
description | BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definitions, incorporating clinical criteria to better understand the rate of co-infections and antibiotic use in COVID-19. METHODS: A total of 1016 adult patients admitted to 5 hospitals in the Johns Hopkins Health System between March 1, 2020, and May 31, 2020, with COVID-19 were evaluated. Adjudication of co-infection using definitions developed by a multidisciplinary team for this study was performed. Both respiratory and common nonrespiratory co-infections were assessed. The definition of bacterial community-acquired pneumonia (bCAP) included proven (clinical, laboratory, and radiographic criteria plus microbiologic diagnosis), probable (clinical, laboratory, and radiographic criteria without microbiologic diagnosis), and possible (not all clinical, laboratory, and radiographic criteria met) categories. Clinical characteristics and antimicrobial use were assessed in the context of the consensus definitions. RESULTS: Bacterial respiratory co-infections were infrequent (1.2%); 1 patient had proven bCAP, and 11 (1.1%) had probable bCAP. Two patients (0.2%) had viral respiratory co-infections. Although 69% of patients received antibiotics for pneumonia, the majority were stopped within 48 hours in patients with possible or no evidence of bCAP. The most common nonrespiratory infection was urinary tract infection (present in 3% of the cohort). CONCLUSIONS: Using multidisciplinary consensus definitions, proven or probable bCAP was uncommon in adults hospitalized due to COVID-19, as were other nonrespiratory bacterial infections. Empiric antibiotic use was high, highlighting the need to enhance antibiotic stewardship in the treatment of viral pneumonias. |
format | Online Article Text |
id | pubmed-7793465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77934652021-01-13 Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study Karaba, Sara M Jones, George Helsel, Taylor Smith, L Leigh Avery, Robin Dzintars, Kathryn Salinas, Alejandra B Keller, Sara C Townsend, Jennifer L Klein, Eili Amoah, Joe Garibaldi, Brian T Cosgrove, Sara E Fabre, Valeria Open Forum Infect Dis Major Articles BACKGROUND: Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definitions, incorporating clinical criteria to better understand the rate of co-infections and antibiotic use in COVID-19. METHODS: A total of 1016 adult patients admitted to 5 hospitals in the Johns Hopkins Health System between March 1, 2020, and May 31, 2020, with COVID-19 were evaluated. Adjudication of co-infection using definitions developed by a multidisciplinary team for this study was performed. Both respiratory and common nonrespiratory co-infections were assessed. The definition of bacterial community-acquired pneumonia (bCAP) included proven (clinical, laboratory, and radiographic criteria plus microbiologic diagnosis), probable (clinical, laboratory, and radiographic criteria without microbiologic diagnosis), and possible (not all clinical, laboratory, and radiographic criteria met) categories. Clinical characteristics and antimicrobial use were assessed in the context of the consensus definitions. RESULTS: Bacterial respiratory co-infections were infrequent (1.2%); 1 patient had proven bCAP, and 11 (1.1%) had probable bCAP. Two patients (0.2%) had viral respiratory co-infections. Although 69% of patients received antibiotics for pneumonia, the majority were stopped within 48 hours in patients with possible or no evidence of bCAP. The most common nonrespiratory infection was urinary tract infection (present in 3% of the cohort). CONCLUSIONS: Using multidisciplinary consensus definitions, proven or probable bCAP was uncommon in adults hospitalized due to COVID-19, as were other nonrespiratory bacterial infections. Empiric antibiotic use was high, highlighting the need to enhance antibiotic stewardship in the treatment of viral pneumonias. Oxford University Press 2020-12-21 /pmc/articles/PMC7793465/ /pubmed/33447639 http://dx.doi.org/10.1093/ofid/ofaa578 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Articles Karaba, Sara M Jones, George Helsel, Taylor Smith, L Leigh Avery, Robin Dzintars, Kathryn Salinas, Alejandra B Keller, Sara C Townsend, Jennifer L Klein, Eili Amoah, Joe Garibaldi, Brian T Cosgrove, Sara E Fabre, Valeria Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title_full | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title_fullStr | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title_full_unstemmed | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title_short | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study |
title_sort | prevalence of co-infection at the time of hospital admission in covid-19 patients, a multicenter study |
topic | Major Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793465/ https://www.ncbi.nlm.nih.gov/pubmed/33447639 http://dx.doi.org/10.1093/ofid/ofaa578 |
work_keys_str_mv | AT karabasaram prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT jonesgeorge prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT helseltaylor prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT smithlleigh prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT averyrobin prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT dzintarskathryn prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT salinasalejandrab prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT kellersarac prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT townsendjenniferl prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT kleineili prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT amoahjoe prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT garibaldibriant prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT cosgrovesarae prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy AT fabrevaleria prevalenceofcoinfectionatthetimeofhospitaladmissionincovid19patientsamulticenterstudy |